Long-Term Efficacy of Selective Laser Trabeculoplasty in Primary Angle-Closure Disease After Laser Peripheral Iridotomy

REFERENCES

• Sommer A, Tielsch JM, Katz J, Quigely HA, et al. Racial differences in the cause specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325(20):1412–1417. doi:10.1056/NEJM199111143252004.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Cheng J-W, Zong Y, Zeng Y-Y, Acott TS, et al. The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. Plos One. 2014;9(7):e103222. doi:10.1371/journal.pone.0103222.
   PubMed Web of Science ®Google Scholar
• Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017;390(10108):2183–93. doi:10.1016/S0140-6736(17)31469-1.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Measuring visualfield progression in the early manifest GlaucomaTrial. ActaOphthalmolscand. 2003;81(3):286–293. doi:10.1034/j.1600-0420.2003.00070.x.
   Web of Science ®Google Scholar
• Robin AL, Pollack IP. Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Long-term follow-up. Arch Ophthalmol. 1982;100(6):919–923. doi:10.1001/archopht.1982.01030030927004.
   PubMedGoogle Scholar
• Ali Aljasim L, Owaidhah O, Edward DP. Selective laser trabeculoplasty in primary angle-closure glaucoma after laser peripheral iridotomy: a case–control study. J Glaucoma. 2016;25(3):e253–58. doi:10.1097/IJG.0000000000000282.
   PubMed Web of Science ®Google Scholar
• Peng PH, Nguyen H, Lin HS, et al. Long-term outcomes of laser iridotomy in Vietnamese patients with primary angle closure. Br J Ophthalmol. 2011;95(9):1207–1211. doi:10.1136/bjo.2010.181016.
   PubMed Web of Science ®Google Scholar
• Quek DT, Ong GT, Perera SA, et al. Persistence of patients receiving topical glaucoma monotherapy in an Asian population. Arch Ophthalmol. 2011;129(5):643–648. doi:10.1001/archophthalmol.2010.345.
   PubMedGoogle Scholar
• Raj S, Tigari B, Faisal TT, et al. Efficacy of selective laser trabeculoplasty in primary angle closure disease. Eye (Lond). 2018;32(11):1710–1716. doi:10.1038/s41433-018-0165-5.
   PubMed Web of Science ®Google Scholar
• De Keyser M, De Belder M, De Belder S, et al. Where does selective laser trabeculoplasty stand now? A review. Eye Vis (Lond). 2016;3(1):10. doi:10.1186/s40662-016-0041-y.
   PubMedGoogle Scholar
• Best UP, Domack H, Schmidt V. Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty—a controlled prospectiveclinical trial on 284 eyes. KlinMonblAugenheilkd. 2007;224:173–179.
   Google Scholar
• McIlraith I, Strasfeld M, Colev G. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006;15(2):124–130. doi:10.1097/00061198-200604000-00009.
   PubMed Web of Science ®Google Scholar
• Ho CL, Lai JS, Aquino MV, et al. Selective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy. J Glaucoma. 2009;18(7):563–566. doi:10.1097/IJG.0b013e318193c2d1.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy A, Leung CK, Istiantoro DV, et al. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial. JAMA Ophthalmol. 2015;133(2):206–212. doi:10.1001/jamaophthalmol.2014.4893.
   PubMed Web of Science ®Google Scholar
• Foster PJ, Buhrmann R, Quigley HA, et al. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–242. doi:10.1136/bjo.86.2.238.
   PubMed Web of Science ®Google Scholar
• Hodapp E, RK P II, Anderson DR. Clinical Decisions in Glaucoma. St Louis, MO: CV Mosby. 1993:52–61.
   Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization ofuveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Matos AG, Asrani SG, Paula JS. Feasibility of laser trabeculoplasty in angle closure glaucoma: a review of favorable histopathological findings in narrow angles. Clin Exp Ophthalmol. 2017;45(6):632–639. doi:10.1111/ceo.12938.
   PubMed Web of Science ®Google Scholar
• Reardon G, Schwartz GF, Mozaffari E. Patient persistency with ocular prostaglandin therapy a population-based, retrospective study. Clin Ther. 2003;25(4):1172–1185. doi:10.1016/S0149-2918(03)80074-7.
   PubMed Web of Science ®Google Scholar
• Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol. 2004;137(suppl):S3–S12. doi:10.1016/j.ajo.2003.10.035.
   PubMedGoogle Scholar
• Katz LJ, Steinmann WC, Kabir A, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma. 2012;21(7):460–468. doi:10.1097/IJG.0b013e318218287f.
   PubMed Web of Science ®Google Scholar
• Nagar M, Ogunyomade A, O’Brart DP, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br JOphthalmol. 2005;89(11):1413–1417. doi:10.1136/bjo.2004.052795.
   PubMed Web of Science ®Google Scholar
• Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentrerandomised controlled trial. Lancet. 2019;393(10180):1505–1516. doi:10.1016/S0140-6736(18)32213-X.
   PubMed Web of Science ®Google Scholar
• Kurysheva NI, Lepeshikina LV, Shatalova EO. Predictors of Outcome in Selective Laser Trabeculoplasty: A Long-term Observation Study in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy Compared With Primary Open-angle Glaucoma. J Glaucoma. 2018;27(10):880–886. doi:10.1097/IJG.0000000000001048.
   PubMed Web of Science ®Google Scholar
• Chen E, Golchin S, Blomdahl S. A comparison between 90° and 180° selective laser trabeculoplasty. J Glaucoma. 2004;13(1):62–65. doi:10.1097/00061198-200402000-00012.
   PubMed Web of Science ®Google Scholar
• Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open-angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degreeSLT. J Glaucoma. 2012;21(1):17–21. doi:10.1097/IJG.0b013e3181fc8020.
   PubMed Web of Science ®Google Scholar
• Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. CurrOpinophthalmol. 2007;18(2):140–145. doi:10.1097/ICU.0b013e328086aebf.
   Web of Science ®Google Scholar
• Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Qswitched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology. 1998;105(11):2082–2090. doi:10.1016/S0161-6420(98)91129-0.
   PubMed Web of Science ®Google Scholar